Table 2.
Retinopathy status | Placebo | Enalapril/losartan |
---|---|---|
n | 74 | 149 |
None (%) | 27 (36.5) | 49 (32.9) |
Mild NPDR (%) | 42 (56.8) | 85 (57.0) |
Moderate to severe NPDR (%) | 5 (6.8) | 15 (10.1) |
NPDR, nonproliferative diabetic retinopathy.
Retinopathy status | Placebo | Enalapril/losartan |
---|---|---|
n | 74 | 149 |
None (%) | 27 (36.5) | 49 (32.9) |
Mild NPDR (%) | 42 (56.8) | 85 (57.0) |
Moderate to severe NPDR (%) | 5 (6.8) | 15 (10.1) |
NPDR, nonproliferative diabetic retinopathy.